Important: this practice guideline applies to care provided to all individuals within the rochester area, including those who are members of a rochester area managed care plan
Approach to Adult Patient Unable to Maintain Nutrition
□ Weight Change □ Body Mass Index □ Lab Tests: albumin, prealbumin, cholesterol, lymphocyte count □ Hydration Status (skin turgor, heart rate, BUN/creatinine) □ Urine Output □ Other: ______________________________________________________________________ Comments about above factors: _____________________________________________________________________ _______________________________________________________________________________________________
Factors that Impede Ability to Take in Food
□ Physical Limitations □ Pain □ Visual Problems □ Chewing Problems: mouth, teeth, dentures □ Swallowing Problems: cough after/while eating, holding bolus, pocketing, position while eating or being fed □ Nausea/Vomiting □ Constipation □ Candidiasis □ Shortness of Breath □ Dementia, Depression, Anxiety □ Communication Problems □ Neurological Conditions □ Other: ______________________________________________________________________ Comments about above factors: ______________________________________________________________________ _______________________________________________________________________________________________
□ Stage of Illness : advanced or end stage illness □ ADL Score (please refer to Appendix G for Clinical Frailty Scale): current ____________ □ ADL Score: 1 month prior to admission ____________
□ Constipation/Fecal Impaction □ Other: ______________________________________________________________________ Comments about above factors: ______________________________________________________________________ _______________________________________________________________________________________________
□ Sedatives: lorazepam, clonazepam, etc. □ Antipsychotics: risperidone, quetiapine, aripiprazole, etc. □ Cholingerics for Alzheimer’s and other dementias: donepezil, galantamine, rivastigmine □ Anticholingerics: tolterodine, oxybutynin chloride □ GI irritants or anorexigencis: NSAIDs, COX IIs, bisphosphonates, opioids, digoxin, theophylline, antibiotics, iron, calcium, memantine, SSRIs □ Other: ______________________________________________________________________ Comments about medications: ________________________________________________________________________ ________________________________________________________________________________________________
Correctable Conditions Identified and Acted Upon and Additional Comments: ________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
Evaluating Clinician: ________________________________________ _______________ ___________________
Guidelines are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines should be followed in most cases, but there is an understanding that, depending on the patient, the setting, the circumstances, or other factors, care can and should be tailored to fit individual needs.
Approved April 2013. Next scheduled review by April 2015.
*This program is supported by Salix. Neither Mayo • Microscopic colitis used as umbrella term -subsets collagenous, lymphocytic colitis• Unclear if distinct or parts of a spectrum Which of the following is true regarding patients with microscopic colitis? A) Abdominal pain is uncommon B) Weight loss is uncommon C) Fecal leukocytes are uncommon D) Most meet Rome criteria for
BRAVO Capsule for Esophageal pH Monitoring About the Test : BRAVO pH Test is performed to test for gastro-esophageal reflux disease (GERD). BRAVO is a catheter free pH monitoring device that assists in evaluating the frequency and severity of your acid reflux disease. The BRAVO capsule is placed in the lower or upper esophagus; this may be done at the time of an upper endoscopy (EGD
Copyright 2014 Pdf Medic Finder